Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by SUSAN HILSENBECK and ANNA MALOVANNAYA.
SUSAN HILSENBECK
Connection Strength
0.170
ANNA MALOVANNAYA
  1. Targeting eIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer. J Clin Invest. 2023 12 15; 133(24).
    View in: PubMed
    Score: 0.058
  2. Targeting EIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer. bioRxiv. 2023 Sep 28.
    View in: PubMed
    Score: 0.057
  3. Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approach. iScience. 2023 Jan 20; 26(1):105799.
    View in: PubMed
    Score: 0.054
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.